CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-24 | SCHAFFER DERACE L Director | Purchase | +6,505 | $2.02 | $13K | 251,801 |
| 2017-11-22 | SCHAFFER DERACE L Director | Purchase | +5,261 | $2.10 | $11K | 245,296 |
| 2017-11-21 | SCHAFFER DERACE L Director | Purchase | +7,236 | $2.06 | $15K | 240,035 |
| 2017-11-20 | SCHAFFER DERACE L Director | Purchase | +4,800 | $2.07 | $10K | 232,799 |
| 2017-11-17 | SCHAFFER DERACE L Director | Purchase | +6,295 | $2.12 | $13K | 227,999 |
| 2017-06-06 | Roberts M Scot Chief Scientific Officer | Purchase | +449 | $4.42 | $2K | 449 |
| 2017-05-04 | Drutz David Director | Grant or award · Stock Options (option to buy) | +139 | 139 | ||
| 2017-05-04 | Drutz David Director | Grant or award · Stock Options (option to buy) | +139 | 139 |
Page 29 of 29 · 568 trades